# Antimicrobial Functionalized Mesoporous Silica FDU-12 Loaded with Bacitracin

**Authors:** Dan Adrian Vasile, Ludmila Motelica, Luiza-Andreea Mîrț, Gabriel Vasilievici, Oana-Maria Memecică, Ovidiu Cristian Oprea, Adrian-Vasile Surdu, Roxana Doina Trușcă, Cristina Chircov, Bogdan Ștefan Vasile, Zeno Dorian Ghizdavet, Denisa Ficai, Ana-Maria Albu, Radu Pericleanu, Andreea Ștefania Dumbravă, Mara-Mădălina Mihai, Irina Gheorghe-Barbu, Anton Ficai

PMC · DOI: 10.3390/molecules31020340 · 2026-01-19

## TL;DR

Researchers developed a drug delivery system using mesoporous silica to control the release of bacitracin, an antibiotic, and found it effective against Staphylococcus bacteria.

## Contribution

A novel drug delivery system using functionalized mesoporous silica for controlled bacitracin release with antimicrobial efficacy is introduced.

## Key findings

- Bacitracin-loaded FDU-12 formulations showed strong antimicrobial activity against Staphylococcus strains.
- Sub-inhibitory concentrations reduced microbial adherence and biofilm formation.
- Surface-functionalized FDU-12 modulated virulence factor production in a strain-dependent manner.

## Abstract

The threats leading to the extinction of humanity accelerate the evolution and development of materials that are capable of providing conditions for preserving health and, implicitly, life. In our work, we developed drug delivery systems based on mesoporous silica which can deliver an antibiotic, bacitracin, in a more controlled manner. The synthesis of the FDU-12 was performed through a sol–gel method and alternatively functionalized with -NH2 groups or with poly(N-acryloylmorpholine) chains. The loading of bacitracin was performed using the vacuum-assisted method we successfully used to load these mesoporous materials preferentially within the pores as proved by the TGA-DSC results. The release was performed in two types of simulated body fluid (SBF) and this process was evaluated with chromatographic method using UV detection. The obtained data were fitted in three mathematical models of kinetic drug release (Weibull model, Korsmeyer–Peppas model, and nonlinear regression). The antimicrobial evaluation demonstrated that bacitracin-loaded FDU-12 formulations exhibited strong activity against both reference and clinical Staphylococcus strains. At sub-inhibitory concentrations, all formulations significantly reduced microbial adherence and biofilm formation, although certain strain-dependent stimulatory effects were observed. Furthermore, exposure to sub-MIC levels modulated the production of soluble virulence factors (hemolysins, lipase, and amylase), in a formulation- and strain-dependent manner, underscoring the ability of surface-functionalized FDU-12 carriers to influence bacterial pathogenicity while enhancing antimicrobial efficacy.

## Linked entities

- **Chemicals:** bacitracin (PubChem CID 10909430)

## Full-text entities

- **Chemicals:** FDU-12 (-), silica (MESH:D012822), Bacitracin (MESH:D001414), poly(N-acryloylmorpholine) (MESH:C015460)
- **Species:** Staphylococcus (genus) [taxon 1279]

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844483/full.md

---
Source: https://tomesphere.com/paper/PMC12844483